JUST Biotherapeutics (Acquired)
Just - Evotec Biologics is a Contract Development and Manufacturing Organization (CDMO) that provides development and cGMP manufacturing services for antibody, next-generation biologics, and biosimilar products. They collaborate with clients on antibody discovery, development, process development, and biomanufacturing projects, utilizing expertise in continuous manufacturing to reduce costs and expand global access to affordable, high-quality biotherapeutics.
Industries
Nr. of Employees
large (251-1000)
JUST Biotherapeutics (Acquired)
Seattle, Washington, United States, North America
Products
End-to-end continuous biomanufacturing platform
An integrated continuous manufacturing platform that links perfusion cell culture with continuous downstream purification and automated control to increase throughput and maintain product quality.
Modular cleanroom pod facility design
A modular, pod-based cleanroom approach to house automated continuous biomanufacturing equipment, enabling smaller facility footprints and modular expansion.
End-to-end continuous biomanufacturing platform
An integrated continuous manufacturing platform that links perfusion cell culture with continuous downstream purification and automated control to increase throughput and maintain product quality.
Modular cleanroom pod facility design
A modular, pod-based cleanroom approach to house automated continuous biomanufacturing equipment, enabling smaller facility footprints and modular expansion.
Services
mAb optimization and discovery support
Services to support discovery and optimization of monoclonal antibodies as part of early-stage development programs.
Cell line development services
Generation and screening of production cell lines for recombinant proteins and antibodies to support downstream process development and manufacturing.
Clinical-stage cGMP manufacturing
cGMP manufacturing services tailored to clinical trial supply using intensified and continuous manufacturing processes.
Commercial cGMP manufacturing
Commercial-scale manufacturing enabled by process intensification and continuous processing to support market supply.
Analytical development and QC testing
Analytical method development, characterization and QC testing to support release and stability programs for biologics.
Process development (commercialization-ready)
Development of scalable, robust manufacturing processes to transition biologics from clinical production methods to commercial operations.
mAb optimization and discovery support
Services to support discovery and optimization of monoclonal antibodies as part of early-stage development programs.
Cell line development services
Generation and screening of production cell lines for recombinant proteins and antibodies to support downstream process development and manufacturing.
Clinical-stage cGMP manufacturing
cGMP manufacturing services tailored to clinical trial supply using intensified and continuous manufacturing processes.
Commercial cGMP manufacturing
Commercial-scale manufacturing enabled by process intensification and continuous processing to support market supply.
Analytical development and QC testing
Analytical method development, characterization and QC testing to support release and stability programs for biologics.
Process development (commercialization-ready)
Development of scalable, robust manufacturing processes to transition biologics from clinical production methods to commercial operations.
Expertise Areas
- Biologics CDMO services
- Continuous bioprocessing
- Cell line development
- Process development and scale-up
Key Technologies
- Continuous bioprocessing
- Perfusion cell culture
- Continuous downstream purification
- Process intensification